Completed
Misalignment between U.S. disease burden and novel therapy innovation may contribute to an increase in U.S. disease prevalence, morbidity, and premature mortality, and may exacerbate existing health disparities. Closing existing gaps between clinical therapy innovation and unmet population health needs through public and private actions may help reduce health disparities, improve health outcomes, and lower societal costs.
Featured publication
Aligning Investments in Therapeutic Development with Therapeutic Need: Closing the Gap
Consensus Study Report
·2025
The United States is a global leader in biomedical research, generating therapeutic breakthroughs that advance the health of the nation and the world. The public and private sectors contribute to this advancement by funding biomedical research and development. The current level of investment in phar...
View details